Live Cell Therapies updates

Live Cell Therapies news coverage of developments with the latest updates. Stay on top of latest Cell Therapies news stories and find out what just happened, what is going on with Cell Therapies. The latest real-time news updates and headlines on Cell Therapies
Cells Surf Chemical Waves to Form Collectives
Class II/III BRAF Alterations in NSCLC: Unique Outcomes
New Immunotherapy Doubles Survival in Advanced NSCLC
Early Brain Radiation Benefits EGFR-mutant NSCLC Patients
IASLC Tumor Budding Grade Flags High-Risk Lung Cancer
New Culture Membrane Mimics Intestinal Environment
Fecal Transplant Promises Relief for Immunotherapy Colitis
Eye Scans Detect Atrial Fibrillation 4 Years Early
Georgetown Reveals PAPILLON Trial: Long-Term Lung Cancer Survival
Microproteins Transform Alzheimer's Research Approach
MRI Brain Watch Beats Cranial Radiation in Lung Cancer
Stanford AI Model Revolutionizes Cell Biology
Building Evolutionary Traps for Viruses
Hormone Pollution Turns Male Fish Fiercer, Poorer Dads
UBC Study Reveals Early Decline in Huntington Patients
Cellular Senescence Trumps Mutations in Aging Evidence
Blind Retina Noise May Hinder Sight Restoration
Stress Hormone Timing Creates Different Kind Of Obesity
New Method Tested Against Bacterial Toxin In Brain
Shingles Pain Lingers: Scientists Uncover Causes
Research: Cancer Protein Binds Chromosome Unexpectedly
Exosome Study Uncovers Shingles Pain Relief Pathways
Landmark Study Redefines Rare Disorders
Can Ink Stay In Skin?
Ecosystem Study in Earth's Fastest-Warming Region
Hanbat Univ. Unveils Separator To Boost Lithium Battery
DNA Organization Key to Tissue Regeneration, Study Finds
Probing Origins of Childhood Cancer Tumors
Magnetic Pulses Reprogram Immune Cells to Combat Cancer
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
MIT Spinout Transforms Plastic Waste into Building Materials
KAIST Team Reveals Neuron RNA Delivery Mechanism
Amivantamab-Chemo Yields Best Survival in EGFR NSCLC
Zidesamtinib Shows 93% Response in ROS1-positive NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
PBS Adds First Biologic for Uncontrolled COPD
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Ivonescimab Boosts Survival in PD-L1+ Advanced NSCLC
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
Pumitamig Plus Elfetabart Shows Promise in Lung Cancer
Tarlatamab Dosing Shows Promise in Small Cell Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Phase 1 Backs Phase 3 Dose for Lung Cancer Drug
Atezolizumab Combo Doubles Event-Free Survival in NSCLC